AAAAAA
Results:
1-22
|
Results: 22
Authors:
Ossewaarde, ME
Bots, ML
Bak, AAA
Van der Schouw, YT
Witteman, JCM
Planellas, J
Bennink, HJTC
Grobbee, DE
Citation: Me. Ossewaarde et al., Effect of hormone replacement therapy on lipids in perimenopausal and early postmenopausal women, MATURITAS, 39(3), 2001, pp. 209-216
Authors:
Hak, AE
Bak, AAA
Lindemans, J
Planellas, J
Bennink, HJTC
Hofman, A
Grobbee, DE
Witteman, JCM
Citation: Ae. Hak et al., The effect of hormone replacement therapy on serum homocysteine levels in perimenopausal women: a randomized controlled trial, ATHEROSCLER, 158(2), 2001, pp. 437-443
Authors:
de Jong, D
Macklon, NS
Eijkemans, MJC
Mannaerts, BMJL
Bennink, HJTC
Fauser, BCJM
Citation: D. De Jong et al., Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon), FERT STERIL, 75(4), 2001, pp. 688-693
Authors:
Doren, M
Rubig, A
Bennink, HJTC
Holzgreve, W
Citation: M. Doren et al., Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetatereplacement therapy, FERT STERIL, 75(3), 2001, pp. 554-559
Authors:
Biswas, A
Viegas, OAC
Bennink, HJTC
Korver, T
Ratnam, SS
Citation: A. Biswas et al., Implanon (R) contraceptive implants: effects on carbohydrate metabolism, CONTRACEPT, 63(3), 2001, pp. 137-141
Authors:
Berning, B
van Kuijk, C
Bennink, HJTC
Fauser, BCJM
Citation: B. Berning et al., Absent correlation between vaginal bleeding and oestradiol levels or endometrial morphology during tibolone use in early postmenopausal women, MATURITAS, 35(1), 2000, pp. 81-88
Authors:
van Heusden, AM
Killick, SR
Bennink, HJTC
Fauser, BCJM
Citation: Am. Van Heusden et al., Single monthly administration of the anti-progestagen Org 31710 in users of the 75 mu g desogestrel progestagen-only pill: effects on pituitary-ovarian activity, HUM REPR, 15(3), 2000, pp. 629-636
Authors:
Spitz, IM
Van Look, PFA
Bennink, HJTC
Citation: Im. Spitz et al., The use of progesterone antagonists and progesterone receptor modulators in contraception, STEROIDS, 65(10-11), 2000, pp. 817-823
Authors:
Spitz, IM
Bennink, HJTC
Citation: Im. Spitz et Hjtc. Bennink, Progesterone receptor modulators at the start of a new millennium, STEROIDS, 65(10-11), 2000, pp. 837-838
Authors:
Bennink, HJTC
Citation: Hjtc. Bennink, The Jerusalem declaration on progesterone receptor modulators, STEROIDS, 65(10-11), 2000, pp. 839-839
Authors:
Westendorp, ICD
de Kleijn, MJJ
Bots, ML
Bak, AAA
Planellas, J
Bennink, HJTC
Hofman, A
Grobbee, DE
Witteman, JCM
Citation: Icd. Westendorp et al., The effect of hormone replacement therapy on arterial distensibility and compliance in perimenopausal women: a 2-year randomised trial, ATHEROSCLER, 152(1), 2000, pp. 149-157
Authors:
Winkler, UH
Altkemper, R
Kwee, B
Helmond, FA
Bennink, HJTC
Citation: Uh. Winkler et al., Effects of tibolone and continuous combined hormone replacement therapy onparameters in the clotting cascade: a multicenter, double-blind, randomized study, FERT STERIL, 74(1), 2000, pp. 10-19
Authors:
Biswas, A
Viegas, OAC
Bennink, HJTC
Korver, T
Ratnam, SS
Citation: A. Biswas et al., Effect of Implanon((R)) use on selected parameters of thyroid and adrenal function, CONTRACEPT, 62(5), 2000, pp. 247-251
Authors:
Doren, M
Rubig, A
Bennink, HJTC
Holzgreve, W
Citation: M. Doren et al., Resistance of pelvic arteries and plasma lipids in postmenopausal women: Comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy, AM J OBST G, 183(3), 2000, pp. 575-582
Authors:
Doren, M
Rubig, A
Bennink, HJTC
Holzgreve, W
Citation: M. Doren et al., Impact on uterine bleeding and endometrial thickness: Tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy, MENOPAUSE, 6(4), 1999, pp. 299-306
Authors:
Pavlov, PW
Ginsburg, J
Kicovic, PM
van der Schaaf, DB
Prelevic, G
Bennink, HJTC
Citation: Pw. Pavlov et al., Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures, GYNECOL END, 13(4), 1999, pp. 230-237
Authors:
de Kleijn, MJJ
Bots, ML
Bak, AAA
Westendorp, ICD
Planellas, J
Bennink, HJTC
Witteman, JCM
Grobbee, DE
Citation: Mjj. De Kleijn et al., Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness, MATURITAS, 32(3), 1999, pp. 195-204
Authors:
Berning, B
von Kuijk, C
Kuiper, JW
Bennink, HJTC
Fauser, BCJM
Citation: B. Berning et al., Increased loss of trabecular but not cortical bone density, 1 year after discontinuation of 2 years hormone replacement therapy with Tibolone, MATURITAS, 31(2), 1999, pp. 151-159
Authors:
Out, HJ
Bennink, HJTC
de Laat, WNGM
Citation: Hj. Out et al., What are the clinical benefits of recombinant gonadotrophins? The development of recombinant FSH (Puregon (R)): a scientific business, HUM REPR, 14(9), 1999, pp. 2189-2190
Authors:
Affandi, B
Korver, T
Geurts, TBP
Bennink, HJTC
Citation: B. Affandi et al., A pilot efficacy study with a single-rod contraceptive implant (Implanon (R)) in 200 Indonesian women treated for <= 4 years, CONTRACEPT, 59(3), 1999, pp. 167-174
Authors:
Out, HJ
Bennink, HJTC
Citation: Hj. Out et Hjtc. Bennink, Clomiphene citrate or gonadotrophins for induction of ovulation?, HUM REPR, 13(9), 1998, pp. 2358-2361
Authors:
Bennink, HJTC
Citation: Hjtc. Bennink, Introduction - Presentation of clinical data on Implanon (R), CONTRACEPT, 58(6), 1998, pp. 75S-77S
Risultati:
1-22
|